You searched for "bleeding"
The TOPCON / OIA Imaging Competition and a brief history of ophthalmic photography
We hope you like and appreciate the image forming the cover of the June/July 2021 edition of Eye News. The Ophthalmic Imaging Association (OIA) was honoured to have been invited to submit a series of images from the winners of...Well-presented scholarly research work will reduce chances of journal rebuttal
1 April 2018
| Rod McNeil
|
EYE - General
Submitting to an academic journal? Are you aware of the requirements and constraints of relevant copyright laws? Rod McNeil provides a guide for aspiring authors. Getting published in peer-reviewed academic and medical journals is not easy. But careful attention to...
Patients use their own blood to treat dry eye symptoms
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’? Headline: Patients use their own blood to treat dry eye symptoms Grossman first described the technique of...Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...Acute macular neuroretinopathy
3 April 2024
| Sagar Jobanputra, Marcela Bohn
|
EYE - Vitreo-Retinal
Acute macular neuroretinopathy (AMN) is a rare condition that typically affects young women and presents with photopsia and paracentral scotomata [1]. We describe a case of severe acute macular neuroretinopathy, following Covid-19 infection. A 30-year-old woman presented to the urgent...
A case of ‘60-day glaucoma’
3 April 2023
| Jagruti Godhaniya, Rajan Paul
|
EYE - General
Neovascular glaucoma (NVG) has been called ‘90-’ or ‘100-day glaucoma’ in the past due to its typical development three months after the onset of central retinal vein occlusion (CRVO). In reality, NVG can occur anywhere between two weeks and two...
Innovation update: key advances in eyecare transformation in the last year
1 December 2021
| Vishal Shah, Alexander Chiu, Guy Mole, Melanie Hingorani
|
EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
Vishal Shah and his co-authors reflect on examples of innovation in eyecare delivery published in the last year and the implications for the future of eyecare services. The “new normal” is an overused phrase to describe extraordinary measures that have...
A closer look at the new wave of glaucoma surgery – radical or old school?
1 October 2016
| Demetrios T Manasses, Leon Au
|
EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...
Treatment of diabetic macular oedema
1 June 2014
| Samantha S Mann
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...
‘Step Up For Nystagmus’ this Nystagmus Awareness Day
20 June 2022
Monday 20 June, the Nystagmus Network marks Nystagmus Awareness Day by asking supporters to ‘Step Up For Nystagmus’ to raise awareness of this complex visual impairment.
European experts working with Royal Blind School on future of vision impairment education
31 March 2023
|
3D printing, Education
Vision impairment education experts from Germany, Holland and Spain recently visited the Royal Blind School in Edinburgh to create a catalogue of objects that can be 3D printed.
